Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Repligen Corporation - Common Stock (NQ:RGEN)

130.86 +2.36 (+1.84%)
Streaming Delayed Price Updated: 3:52 PM EDT, Apr 2, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 439,553
Open 126.72
Bid (Size) 130.76 (1)
Ask (Size) 131.19 (1)
Prev. Close 128.50
Today's Range 124.99 - 133.38
52wk Range 113.50 - 184.98
Shares Outstanding 55,679,964
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Winners And Losers Of Q4: IQVIA (NYSE:IQV) Vs The Rest Of The Drug Development Inputs & Services Stocks
The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current business environment. Let’s take a look at how IQVIA (NYSE:IQV) and the rest... 
Via StockStory
Drug Development Inputs & Services Stocks Q4 In Review: Medpace (NASDAQ:MEDP) Vs Peers
Wrapping up Q4 earnings, we look at the numbers and key takeaways for the drug development inputs & services stocks, including Medpace (NASDAQ:MEDP) and its peers. 
Via StockStory

Performance

YTD
-8.5%
-8.5%
1 Month
-15.8%
-15.8%
3 Month
-9.1%
-9.1%
6 Month
-10.2%
-10.2%
1 Year
-28.5%
-28.5%

More News

Read More
Demystifying Repligen: Insights From 6 Analyst Reviews
Via Benzinga
Q4 Rundown: PacBio (NASDAQ:PACB) Vs Other Life Sciences Tools & Services Stocks
Via StockStory
Topics Artificial Intelligence
Exposures Artificial Intelligence
The Analyst Verdict: Repligen In The Eyes Of 4 Experts
Via Benzinga
Earnings Scheduled For February 20, 2025
Via Benzinga
Earnings Scheduled For November 12, 2024
Via Benzinga
Evaluating Repligen: Insights From 6 Financial Analysts
Via Benzinga
Q4 Earnings Recap: Azenta (NASDAQ:AZTA) Tops Drug Development Inputs & Services Stocks
Via StockStory
A Look Back at Drug Development Inputs & Services Stocks’ Q4 Earnings: Repligen (NASDAQ:RGEN) Vs The Rest Of The Pack
Via StockStory
3 Small-Cap Stocks Skating on Thin Ice
Via StockStory
908 Devices Strategic Shift: Desktop Sale To Repligen Optimizes Future Growth
Via Benzinga
These Analysts Revise Their Forecasts On Repligen Following Q2 Results
Via Benzinga
Repligen Q4 Earnings Momentum Highlights Market Growth, Issues Strong 2025 Outlook
Via Benzinga
Repligen's Q4 Slightly Tops Expectations
Via The Motley Fool
Repligen (NASDAQ:RGEN) Posts Q4 Sales In Line With Estimates
Via StockStory
Exposures COVID-19
Earnings To Watch: Repligen (RGEN) Reports Q4 Results Tomorrow
Via StockStory
3 Healthcare Stocks Skating on Thin Ice
Via StockStory
Topics Stocks
Exposures COVID-19 US Equities
Repligen Q3 Earnings Beat Expectations, Highlights Improving Market Conditions, Analyst Says Well-Positioned For Long-Term Growth
Via Benzinga
Topics Earnings
Exposures Financial
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
Wall Street Ticks Up As Consumer Sentiment Improves; Gold Hits Record Highs, Boosting Mining Stocks: What's Driving Markets Friday?
Via Benzinga
Shake Shack And Lumen Tech Are Among Top 7 Mid Cap Stocks With Max Gains Last Week (July 28-August 3): Are The Others In Your Portfolio?
Via Benzinga
Here's Why Shares in This Hot Healthcare Stock Surged This Week
Via The Motley Fool
Why Merck Shares Are Trading Lower By 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
Repligen Lowers Guidance On China Weakness, Analyst Expects
Via Benzinga

Frequently Asked Questions

Is Repligen Corporation - Common Stock publicly traded?
Yes, Repligen Corporation - Common Stock is publicly traded.
What exchange does Repligen Corporation - Common Stock trade on?
Repligen Corporation - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Repligen Corporation - Common Stock?
The ticker symbol for Repligen Corporation - Common Stock is RGEN on the Nasdaq Stock Market
What is the current price of Repligen Corporation - Common Stock?
The current price of Repligen Corporation - Common Stock is 130.86
When was Repligen Corporation - Common Stock last traded?
The last trade of Repligen Corporation - Common Stock was at 04/02/25 03:52 PM ET
What is the market capitalization of Repligen Corporation - Common Stock?
The market capitalization of Repligen Corporation - Common Stock is 7.29B
How many shares of Repligen Corporation - Common Stock are outstanding?
Repligen Corporation - Common Stock has 7B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.